FDA
- Status: approved
🇺🇸 Famtozinameran 12 Years of age and older in United States
Famtozinameran 12 Years of age and older (famtozinameran-12-years-of-age-and-older) regulatory status in United States.
Marketing authorisation
Pricing & reimbursement
- annual_list: USD 80000.00 per year
Famtozinameran 12 Years of age and older in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Famtozinameran 12 Years of age and older approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Famtozinameran 12 Years of age and older in United States?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.
What does Famtozinameran 12 Years of age and older cost in United States?
annual_list: USD 80000.00 per year. Final patient cost depends on reimbursement and any patient access scheme.